Company news

DSM-Firmenich AG news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Sustell and SustainCERT partner to connect footprint measurement, verification and carbon registry capabilities

November 4, 2026

Dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen’s decision to retire

August 18, 2026

Dsm-firmenich reports H1 2026 results

July 30, 2026

Dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S.

June 10, 2026

Dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam

May 21, 2026

dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2026

May 7, 2026

dsm-firmenich Q1 2026 trading update

May 6, 2026

Weekly progress on share repurchase program to cover share plans and reduce capital

April 28, 2026

dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation

March 12, 2026

dsm-firmenich announces share repurchase program to cover share plans and reduce capital

March 12, 2026

dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program

February 26, 2026

dsm-firmenich publishes 2025 Integrated Annual Report

February 20, 2026

dsm-firmenich issues €1.5 billion long-term bonds

February 17, 2026

dsm-firmenich reports full year 2025 results

February 12, 2026

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

February 9, 2026

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

February 9, 2026

dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer

January 14, 2026

dsm-firmenich completes €1.08 billion share repurchase program

December 2, 2025

dsm-firmenich Q3 2025 trading update

October 30, 2025

dsm-firmenich achieves target of 100% purchased renewable electricity

September 3, 2025

dsm-firmenich strengthens its Executive Committee for future growth as a consumer-focused company

September 1, 2025

dsm-firmenich reports H1 2025 results

July 31, 2025

dsm-firmenich announces redemption of €750 million hybrid bond

July 1, 2025

dsm-firmenich announces increase in share repurchase program to reduce capital to €1 billion

June 27, 2025

dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

June 2, 2025

dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2025

May 6, 2025

dsm-firmenich Q1 2025 trading update

April 30, 2025

Calls

The 5 newest of 14 calls. Every call is listed under its year.

Decks

The 5 newest of 104 decks. Every deck is listed under its year.